ROY M AMBINDER M. D. NPI 1770549115

NPI Details

Roy M Ambinder, M. D. is a medical oncology internal medicine in Altamonte Springs, FL. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Roy M Ambinder, M. D. NPI is 1770549115. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

106 BOSTON AVE STE 105
ALTAMONTE SPRINGS, FL
ZIP 32701-711
Phone: (407) 553-7710
Fax: (866) 445-1446

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, omalizumab, 5 mg (HCPCS:J2357)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Blood test, clotting time (HCPCS:85610)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Folic acid level, serum (HCPCS:82746)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Protein measurement, serum (HCPCS:84165)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Uric acid level, blood (HCPCS:84550)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection of drug or substance into vein (HCPCS:96374)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Magnesium level (HCPCS:83735)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Drawing of blood for a medical problem (HCPCS:99195)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Vitamin d-3 level (HCPCS:82306)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Homocysteine (amino acid) level (HCPCS:83090)
• Hemoglobin analysis and measurement, electrophoresis (HCPCS:83020)
• Hepatitis b core antibody measurement (HCPCS:86704)

The enumeration date for this NPI number is 4/25/2006 and was last updated on 8/3/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.